Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial

Shu-Lian Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Fang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yong-Wen Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei-Hu Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chen Hu(Johns Hopkins University), Yue-Ping Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Jin(Chinese Academy of Medical Sciences & Peking Union Medical College), Xin-Fan Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zi-Hao Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Hua Ren(Chinese Academy of Medical Sciences & Peking Union Medical College), Ning Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Ning-Ning Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu Tang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuan Yan Tang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shu‐Nan Qi(Chinese Academy of Medical Sciences & Peking Union Medical College), Guang-Yi Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Ran Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuai Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yong Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ye‐Xiong Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
The Lancet Oncology
January 30, 2019
Cited by 401

Abstract


Related Papers

No related papers found

Powered by citation graph analysis